Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 339, Issue 3, 2011, Pages 790-798

  Haub, Synia ^a   Ritze, Yvonne ^a   Ladel, Inga ^a   Saum, Karolin ^a   Hubert, Astrid ^a   Spruss, Astrid ^a   Trautwein, Christian ^b   Bischoff, Stephan C ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CLAUDIN 1; ENDOTOXIN; LEPTIN; MEMBRANE PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; OCCLUDIN; PALONOSETRON; SEROTONIN; SEROTONIN 3 RECEPTOR; SEROTONIN TRANSPORTER; TIGHT JUNCTION PROTEIN; TROPISETRON; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUODENUM; FAT CONTENT; GENE EXPRESSION; HEPATITIS; INTESTINE INNERVATION; LIVER INJURY; LIVER NECROSIS; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PORTAL VEIN; PRIORITY JOURNAL; TISSUE LEVEL;

ACTINS; ANIMALS; AZO COMPOUNDS; DRUG EVALUATION, PRECLINICAL; DUODENUM; ENDOTOXINS; FATTY LIVER; INDOLES; INFLAMMATION; ISOQUINOLINES; LEPTIN; LIVER; MICE; MICE, OBESE; OBESITY; PROTEINS; QUINUCLIDINES; SEROTONIN; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 81555204260     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.181834     Document Type: Article

References (33)

1. Abdrakhmanova GR, AlSharari S, Kang M, Damaj MI, and Akbarali HI (2010) {alpha}7-nAChR-mediated suppression of hyperexcitability of colonic dorsal root ganglia neurons in experimental colitis. Am J Physiol Gastrointest Liver Physiol 299:G761-G768.
2. Anstee QM and Goldin RD (2006) Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 87:1-16.
3. Arteel GE (2003) Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 124:778-790.
4. Bakker R, Dekker K, De Jonge HR, and Groot JA (1993) VIP, serotonin, and epinephrine modulate the ion selectivity of tight junctions of goldfish intestine. Am J Physiol 264:R362-R368. (Pubitemid 23085899)
5. Bergheim I, Weber S, Vos M, Krämer S, Volynets V, Kaserouni S, McClain CJ, and Bischoff SC (2008) Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 48:983-992.
6. Bischoff SC, Mailer R, Pabst O, Weier G, Sedlik W, Li Z, Chen JJ, Murphy DL, and Gershon MD (2009) Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice. Am J Physiol Gastrointest Liver Physiol 296:G685-G695.
7. Bode C and Bode JC (2003) Effect of alcohol consumption on the gut. Best Pract Res Clin Gastroenterol 17:575-592.
8. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, and Nusrat A (2003) Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 171:6164-6172. (Pubitemid 37467239)
9. Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palù G, and Martines D (2007) Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292:G518-G525.
10. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, and Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467-2474. (Pubitemid 29420675)
11. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, and Burcelin R (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:1470-1481.
12. Cope K, Risby T, and Diehl AM (2000) Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 119:1340-1347.
13. Costedio MM, Hyman N, and Mawe GM (2007) Serotonin and its role in colonic function and in gastrointestinal disorders. Dis Colon Rectum 50:376-388. (Pubitemid 46394454)
14. Gan TJ (2005) Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same? CNS Drugs 19:225-238.
15. Gershon MD (2004) Review article: serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 20 (Suppl 7):3-14.
16. Haub S, Kanuri G, Volynets V, Brune T, Bischoff SC, and Bergheim I (2010) Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice. Am J Physiol Gastrointest Liver Physiol 298:G335-G344.
17. Hookman P and Barkin JS(2003) Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach. Am J Gastroenterol 98:2093-2097. (Pubitemid 37185811)
18. Ilan Y, Maron R, Tukpah AM, Maioli TU, Murugaiyan G, Yang K, Wu HY, and Weiner HL (2010) Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proc Natl Acad Sci USA 107:9765-9770.
19. Kohnomi S, Suemaru K, Goda M, Choshi T, Hibino S, Kawasaki H, and Araki H (2010) Ameliorating effects of tropisetron on dopaminergic disruption of prepulse inhibition via the alpha(7) nicotinic acetylcholine receptor in Wistar rats. Brain Res 1353:152-158.
20. Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, Desimone C, Song XY, Diehl AM, and Watkins PA (2003) Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37:343-350. (Pubitemid 36152533)
21. Lichtman SN, Keku J, Schwab JH, and Sartor RB (1991) Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology 100:513-519.
22. Macia L, Delacre M, Abboud G, Ouk TS, Delanoye A, Verwaerde C, Saule P, and Wolowczuk I (2006) Impairment of dendritic cell functionality and steady-state number in obese mice. J Immunol 177:5997-6006. (Pubitemid 44628813)
23. Margolis KG and Gershon MD(2009) Neuropeptides and inflammatory bowel disease. Curr Opin Gastroenterol 25:503-511.
24. Mousavizadeh K, Rahimian R, Fakhfouri G, Aslani FS, and Ghafourifar P (2009) Anti-inflammatory effects of 5-HT receptor antagonist, tropisetron on experimental colitis in rats. Eur J Clin Inves 39:375-383.
25. Nanji AA, Tsukamoto H, and French SW (1989) Relationship between fatty liver and subsequent development of necrosis, inflammation and fibrosis in experimental alcoholic liver disease. Exp Mol Pathol 51:141-148. (Pubitemid 20001028)
26. Nylander O and Pihl L (2006) Luminal hypotonicity increases duodenal mucosal permeability by a mechanism involving 5-hydroxytryptamine. Acta Physiol (Oxf) 186:45-58.
27. Spiller R (2007) Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease. Neurogastroenterol Motil 19 (Suppl 2):25-31.
28. Stull MA, Pai V, Vomachka AJ, Marshall AM, Jacob GA, and Horseman ND (2007) Mammary gland homeostasis employs serotonergic regulation of epithelial tight junctions. Proc Natl Acad Sci USA 104:16708-16713. (Pubitemid 350211081)
29. Thompson AJ and Lummis SC (2006) 5-HT3 receptors. Curr Pharm Des 12:3615-3630.
30. Vega Lde L, Muñoz E, Calzado MA, Lieb K, Candelario-Jalil E, Gschaidmeir H, Färber L, Mueller W, Stratz T, and Fiebich BL (2005) The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway. Biochem Pharmacol 70:369-380. (Pubitemid 40905109)
31. Weber S, Volynets V, Kanuri G, Bergheim I, and Bischoff SC (2009) Treatment with the 5-HT3 antagonist tropisetron modulates glucose-induced obesity in mice. Int J Obes (Lond) 33:1339-1347.
32. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, and Cummins AG (2001) The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of nonalcoholic steatohepatitis. Gut 48:206-211. (Pubitemid 32141844)
33. Yamada T, Inui A, Hayashi N, Fujimura M, and Fujimiya M (2003) Serotonin stimulates endotoxin translocation via 5-HT3 receptors in the rat ileum. Am J Physiol Gastrointest Liver Physiol 284:G782-G788. (Pubitemid 36437978)